Research
2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression
Nature ·
The Brief
- A study reports serum 2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression.
- The finding is from a mouse model and has not been shown in humans based on the provided sources.
- The source is a nature.com subject feed entry dated 2026-11-13 with no summary available.
Why it matters
If validated, a blood-based marker could help predict which patients respond to antidepressants, but the evidence here is limited to a mouse model.
Who’s affected
- researchers in depression and psychopharmacology
- clinicians interested in antidepressant response prediction
- #depression
- #fluoxetine
- #biomarker
- #endocannabinoid
- #mouse model